The Effects of Inaccurate Blood Sample Volume on Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT)
Explore this paper's citation graph
Summary
It is concluded that underfilling may produce profound effects, particularly on the aPTT, in contrast to overfilling, which rarely affects the results.
- Type
- article
- Published
- 1982-04-30
- Cited by
- 48
- References
- 8
- OpenAlex
- https://openalex.org/W107393773
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:19445740
Keywords
Partial thromboplastin time, Prothrombin time, Medicine, Thromboplastin, Thrombin time
References
Cited by
- Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin
- Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample.
- The Laboratory of Coagulation A review of present laboratory techniques
- A COMPARISON OF ACTIVATED PARTIAL THROMBOPLASTIN TIME OBTAINED BY TWO TECHNIQUES IN PATIENTS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
- Impact of incorrect filling of citrate blood sampling tubes on thromboelastometry
- Recommandations pratiques pour la réalisation des tests d'hémostase: du prélèvement au contrôle de qualité
- Underestimation of unfractionated heparin therapy assessment due to platelet activation when using partial-draw (pediatric) citrate collection tubes.
- Monitoring anticoagulation following intracoronary procedures: which method?
- Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
- Activated Coagulation and Activated Partial Thromboplastin Times in Assessment and Reversal of Heparin‐Induced Anticoagulation for Cardiopulmonary Bypass
- Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
- QCM-D providing new horizon in the domain of sensitivity range and information for haemostasis of human plasma.
- Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience.
- Quality Standards for Sample Collection in Coagulation Testing
- Clotting Screen Requests in Pediatrics
- Influence of Blood Collection Systems on Coagulation Tests
- Quantification of surgical blood loss.
- Präanalytische Probleme bei Gerinnungsuntersuchungen im venösen Citratblut, Katheterblut und Kapillarblut. Determination of Coagulation Parameters in Citrated Venous Blood, Catheter Blood, and Capillary Blood: Preanalytical Problems
- Clinically relevant differences in prothrombin time and INR values related to blood sample collection in plastic vs glass tubes.
- Diagnostic uses of the activated partial thromboplastin time and prothrombin time.
Related papers
- Influence of the Time and Temperature on the Results of Prothrombin Time,Activated Partial Thromboplastin Time,Thrombin Time and Fibrinogen
- Influence of temperature and storage duration on measurement of activated partial thromboplastin time, D‐dimers, fibrinogen, prothrombin time and thrombin time, in citrate‐anticoagulated whole blood specimens
- Comparison of two laboratory tests in the control of anticoagulant therapy
- Research on Anticoagulation of Caffeine on Mice
- Effects of haemolysis, lipaemia and bilirubinaemia on prothrombin time, activated partial thromboplastin time and thrombin time in plasma samples from healthy dogs.
- Changes in coagulation function in patients with hepatocellular carcinoma and its clinical significance
- Prothrombin time and partial thromboplastin time assay considerations.
- Detection of Blood Coagulation Function in Terminal Pregnant Women and Its Clinical Significance
- Detection and Significance of Blood Coagulation Parameter and Platelet Count Measurement in Patients with Hepato-Lenticular Degeneration
- Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants.